G1 Therapeutics to Participate in the 40th Annual J.P. Morgan and H.C. Wainwright BioConnect Virtual Conferences in January 2022
- G1’s Chief Executive Officer
Jack Bailey and Chief Medical OfficerRaj Malik , M.D. will participate in a fireside chat during the H.C. Wainwright BioConnect 2022 conference. The webcast of the fireside chat will become available at7:00 AM EST onJanuary 10, 2022 .
- On
January 12, 2022 , at1:30 PM EST ,Mr. Bailey will provide a corporate presentation during the 40th AnnualJ.P. Morgan Healthcare Conference .
The webcast of both events will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.
About
Contacts:
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com
Source: G1 Therapeutics